Agreement - November 29, 2013
Egalet enters collaboration with Shionogi
Denmark’s Egalet has entered into a collaboration and license agreement with Shionogi. The collaboration and agreement regards the development and potential commercialization of multiple oral abuse-deterrent hydrocodone opioid product candidates using Egalet’s proprietary technology. Egalet will receive a $10 million upfront payment from Shionogi. Furthermore, Shionogi has agreed to purchase up to approximately $15 million in common stock in a private placement to […]
Uncategorized - October 22, 2013
Shionogi provides funding for Danish research
Shionogi Co has selected Denmark as one of the countries in their Shionogi Science Program 2013. Shionogi Science Program invites researchers from selected countries outside Japan into joint studies. The aim is to invite novel, innovative and world-class ideas from researchers to create new pharmaceuticals. The program will adopt projects with budgets of JPY 5-15 […]
